These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8042819)

  • 1. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
    Stein PD; Hull RD; Raskob G
    Ann Intern Med; 1994 Sep; 121(5):313-7. PubMed ID: 8042819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
    Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
    J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism.
    Meyer G; Gisselbrecht M; Diehl JL; Journois D; Sors H
    Am J Med; 1998 Dec; 105(6):472-7. PubMed ID: 9870831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative risks of anticoagulant treatment of acute pulmonary embolism based on an angiographic diagnosis vs a ventilation/perfusion scan diagnosis.
    Stein PD; Hull RD
    Chest; 1994 Sep; 106(3):727-30. PubMed ID: 8082349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
    Rothschild DP; Goldstein JA; Bowers TR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
    Mikkola KM; Patel SR; Parker JA; Grodstein F; Goldhaber SZ
    Am Heart J; 1997 Jul; 134(1):69-72. PubMed ID: 9266785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis.
    Gao GY; Yang P; Liu M; Ding M; Liu GH; Tong YL; Yang CY; Meng FB
    Thromb Res; 2015 Nov; 136(5):932-7. PubMed ID: 26384442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study.
    Curtis GM; Lam SW; Reddy AJ; Bauer SR
    Pharmacotherapy; 2014 Aug; 34(8):818-25. PubMed ID: 24854996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Systemic Alteplase (tPA) for the Treatment of Pulmonary Embolism.
    Brandt K; McGinn K; Quedado J
    Ann Pharmacother; 2015 Jul; 49(7):818-24. PubMed ID: 25857308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
    Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
    Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Dalen JE
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic thrombolysis for acute pulmonary embolism.
    Bartel B
    Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism.
    Cheely R; McCartney WH; Perry JR; Delany DJ; Bustad L; Wynia VH; Griggs TR
    Am J Med; 1981 Jan; 70(1):17-22. PubMed ID: 7457486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
    Levine MN
    Clin Chest Med; 1995 Jun; 16(2):321-8. PubMed ID: 7656543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter-directed, ultrasound-assisted thrombolysis is a safe and effective treatment for pulmonary embolism, even in high-risk patients.
    Lee KA; Cha A; Kumar MH; Rezayat C; Sales CM
    J Vasc Surg Venous Lymphat Disord; 2017 Mar; 5(2):165-170. PubMed ID: 28214482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications of thrombolytic therapy in pulmonary embolism].
    Meneveau N; Vuillemenot A; Bassand JP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1769-76. PubMed ID: 8815838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.